Dr. Delacroix is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Veterans Memorial Blvd Ste 140
Metairie, LA 70002Phone+1 225-767-0847Fax+1 225-215-1380
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009 - 2012
Ochsner Clinic FoundationResidency, Urology, 2005 - 2009
Louisiana State University School of MedicineInternship, Transitional Year, 2004 - 2005- Louisiana State University School of Medicine in New OrleansClass of 2004
Certifications & Licensure
LA State Medical License 2006 - 2025
MS State Medical License 2024 - 2025
TX State Medical License 2009 - 2025
AL State Medical License 2024 - 2024- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) Start of enrollment: 2021 Mar 17
- A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Start of enrollment: 2019 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01 - Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer.Parminder Singh, Leslie Ballas, Guru P Sonpavde, Ronald C Chen, Rick Bangs
Bladder Cancer. 2024-01-01 - Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.David J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, David J DeGraff, Scott E Delacroix
Bladder Cancer. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
